Stuart Chaussee & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16
| Closed | -$4.51K | – | 10 |
|
|
2025
Q3 | $4.51K | Hold |
16
| – | – | ﹤0.01% | 169 |
|
|
2025
Q2 | $4.47K | Hold |
16
| – | – | ﹤0.01% | 172 |
|
|
2025
Q1 | $4.99K | Hold |
16
| – | – | ﹤0.01% | 175 |
|
|
2024
Q4 | $4.17K | Hold |
16
| – | – | ﹤0.01% | 173 |
|
|
2024
Q3 | $5.16K | Hold |
16
| – | – | ﹤0.01% | 155 |
|
|
2024
Q2 | $5K | Hold |
16
| – | – | ﹤0.01% | 149 |
|
|
2024
Q1 | $4.55K | Hold |
16
| – | – | ﹤0.01% | 149 |
|
|
2023
Q4 | $4.61K | Hold |
16
| – | – | ﹤0.01% | 140 |
|
|
2023
Q3 | $4.3K | Hold |
16
| – | – | ﹤0.01% | 122 |
|
|
2023
Q2 | $3.55K | Hold |
16
| – | – | ﹤0.01% | 124 |
|
|
2023
Q1 | $3.87K | Hold |
16
| – | – | ﹤0.01% | 128 |
|
|
2022
Q4 | $4.2K | Hold |
16
| – | – | ﹤0.01% | 135 |
|
|
2022
Q3 | $4K | Hold |
16
| – | – | 0.01% | 125 |
|
|
2022
Q2 | $4K | Hold |
16
| – | – | 0.01% | 130 |
|
|
2022
Q1 | $4K | Hold |
16
| – | – | ﹤0.01% | 151 |
|
|
2021
Q4 | $4K | Hold |
16
| – | – | ﹤0.01% | 163 |
|
|
2021
Q3 | $3K | Hold |
16
| – | – | ﹤0.01% | 142 |
|
|
2021
Q2 | $4K | Hold |
16
| – | – | ﹤0.01% | 146 |
|
|
2021
Q1 | $4K | Hold |
16
| – | – | ﹤0.01% | 180 |
|
|
2020
Q4 | $4K | Hold |
16
| – | – | ﹤0.01% | 80 |
|
|
2020
Q3 | $4K | Hold |
16
| – | – | ﹤0.01% | 83 |
|
|
2020
Q2 | $4K | Hold |
16
| – | – | ﹤0.01% | 64 |
|
|
2020
Q1 | $3K | Sell |
16
-120
| -88% | -$26.2K | ﹤0.01% | 60 |
|
|
2019
Q4 | $33K | Hold |
136
| – | – | 0.02% | 49 |
|
|
2019
Q3 | $26K | Hold |
136
| – | – | 0.02% | 57 |
|
|
2019
Q2 | $25K | Sell |
136
-130
| -49% | -$23.3K | 0.02% | 58 |
|
|
2019
Q1 | $51K | Buy |
266
+250
| +1,563% | +$47.7K | 0.03% | 43 |
|
|
2018
Q4 | $3K | Hold |
16
| – | – | ﹤0.01% | 87 |
|
|
2018
Q3 | $3K | Hold |
16
| – | – | ﹤0.01% | 105 |
|
|
2018
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 109 |
|
|
2018
Q1 | $3K | Hold |
16
| – | – | 0.01% | 77 |
|
|
2017
Q4 | $3K | Hold |
16
| – | – | ﹤0.01% | 86 |
|
|
2017
Q3 | $3K | Hold |
16
| – | – | ﹤0.01% | 79 |
|
|
2017
Q2 | $3K | Buy |
+16
| New | +$2.6K | ﹤0.01% | 78 |
|
|
2016
Q4 | – | Sell |
-325
| Closed | -$54K | – | 60 |
|
|
2016
Q3 | $54K | Buy |
+325
| New | +$55K | 0.04% | 40 |
|
Other funds holding AMGN
Stuart Chaussee & Associates's AMGN Position: Q4 2025 in Review
Stuart Chaussee & Associates sold out of Amgen (AMGN) in Q4 2025, closing a stake of 16 shares — an estimated $4.51K sold.
Stuart Chaussee & Associates first reported a position in AMGN in Q3 2016 and held it in 35 quarters. The position peaked at $54K in Q3 2016. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Stuart Chaussee & Associates reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Stuart Chaussee & Associates sold 16 Amgen shares in Q4 2025, an estimated $4.51K.
- Stuart Chaussee & Associates first reported a position in Amgen in Q3 2016 and held it in 35 quarters.
- Stuart Chaussee & Associates's Amgen position peaked at $54K in Q3 2016.
- 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.